You will receive alerts when there are new announcements on AEterna Zentaris Inc.
Only registered members can use this feature.
AEterna Zentaris Inc. is a drug development company specialized in oncology and endocrine therapy. The Company’s product pipeline encompasses compounds at all stages of development, from drug discovery through marketed products.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.